Legal Representation
Attorney
David Harper
USPTO Deadlines
Application History
22 eventsDate | Code | Type | Description |
---|---|---|---|
Oct 2, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Oct 2, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Feb 24, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 22, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 22, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
Feb 22, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
Aug 30, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jul 5, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 5, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 15, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 2, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
May 26, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 19, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
May 19, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
May 9, 2016 | ALIE | A | ASSIGNED TO LIE |
Apr 26, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Oct 27, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 27, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED |
Oct 27, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Oct 23, 2015 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 17, 2015 | NWAP | I | NEW APPLICATION ENTERED |
Jul 17, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the treatment of diabetic complications, namely, diabetic nephropathy
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005